Literature DB >> 10728847

AIDS, risk and social governance.

T Brown1.   

Abstract

This paper considers the discursive properties of public health literature produced around AIDS in the 1980s and early 1990s. Attention is focused upon the role of health promotion in the UK government's response to the epidemic and on the language used in the educational campaigns conducted by the Health Education Council and its replacement the Health Education Authority. Using an analytical approach influenced by the work of Michel Foucault, the paper argues that the knowledges of AIDS produced by these various public health institutions constructed discursive boundaries between the idea of 'normal' and 'abnormal' behavioural practices. The notion of risk, produced as it is from epidemiological knowledge, is a central mechanism in this process. It is through the production, articulation and normalisation of 'at risk' groups that society is fragmented and hence subject to the governance strategies of late-modern liberal economies.

Entities:  

Mesh:

Year:  2000        PMID: 10728847     DOI: 10.1016/s0277-9536(99)00370-6

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  4 in total

1.  The pandemic subject: Canadian pandemic plans and communicating with the public about an influenza pandemic.

Authors:  Laena Maunula
Journal:  Healthc Policy       Date:  2013-10

2.  Graphic pathogeographies.

Authors:  Courtney Donovan
Journal:  J Med Humanit       Date:  2014-09

3.  Perceived Risk Among Human Immunodeficiency Virus Serodiscordant Couples in East Africa Taking Oral Pre-Exposure Prophylaxis.

Authors:  Jennifer J Carroll; Renee Heffron; Nelly Mugo; Kenneth Ngure; Patrick Ndase; Stephen Asiimwe; Connie Celum; Jared M Baeten
Journal:  Sex Transm Dis       Date:  2016-08       Impact factor: 2.830

4.  Defining HIV risk and determining responsibility in postsocialist Poland.

Authors:  Jill Owczarzak
Journal:  Med Anthropol Q       Date:  2009-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.